Hormone replacement therapy ‘increases lung cancer risk’March 4th, 2010 - 11:55 am ICT by ANI
Washington, Mar 4 (ANI): Women aged 50 to 76 who use hormone replacement therapy combining estrogen and progestin may have a higher risk of lung cancer than non-users, a new study has found.
Researchers said that although the risk is “duration-dependent,” with women taking HRT for 10-plus years at greatest risk of developing lung cancer, an acceptable length of HRT has yet to be determined.
While the risk of developing lung cancer for women using estrogen plus progestin HRT 10 years or longer was approximately 50 percent more than women not using HRT, this risk is actually quite small compared to the risk from smoking.
“Although HRT use has declined and is not recommended except for short-term treatment of menopausal symptoms, our results indicate millions of women may remain at risk of developing lung cancer,” said Chris Slatore, principal investigator and an assistant professor of medicine in the Oregon Health & Science University School of Medicine, Portland Veterans Affairs Medical Center; and a member of the OHSU Knight Cancer Institute.
For the study, Slatore and colleagues reviewed data collected from 2000 to 2002 in the Vitamins and Lifestyle Study in Washington state.
They identified 36,588 peri- and postmenopausal participants aged 50 to 76 who met their study criteria and followed them for six years using the Seattle-Puget Sound Surveillance, Epidemiology and End Results cancer registry.
At the end of the observation period, December 31, 2007, 344 of the participants had developed lung cancer.
After adjusting for smoking, age and other factors that affect the risk of lung cancer, the researchers determined the use of estrogen and progestin for 10 or more years was associated with increased risk for lung cancer compared with no use of HRT. They also found duration of use was associated with an advanced stage of cancer at diagnosis.
Although the mechanisms underlying the association between HRT and lung cancer are still unknown, the researchers report that genetic and environment interactions likely play a role.
They also suggest that estrogen plus progestin may lead to more aggressive disease or mask early symptoms, or HRT users may be less likely to see or receive medical care in a timely fashion.
“These findings may be useful in counseling women about their risk of developing lung cancer and prompt further research into the mechanisms underlying HRT and increased lung cancer risk,” said Slatore.
The study has been published in the pre-print online edition of the Journal of Clinical Oncology. (ANI)
- Estrogen alone can cut risk of breast cancer - Dec 10, 2010
- Menopausal hormone therapy 'ups ovarian cancer risk' - Nov 10, 2010
- Breast cancer risk varies among different progestins used in hormone replacement therapy - Aug 11, 2010
- HRT raises risk of kidney stones - Oct 13, 2010
- How progesterone and estrogen increase breast cancer risk - Jan 19, 2011
- Hormone therapies 'up breast cancer metastasis risk in post-menopausal women' - May 07, 2010
- Female sex hormone regulates weight - Oct 20, 2011
- Estrogen not linked to lung cancer mortality in postmenopausal women - Aug 14, 2010
- Hormone therapy linked to increased breast cancer risk: Study - Aug 11, 2010
- Anti-estrogen medication 'cuts risk of dying from lung cancer' - Jan 24, 2011
- Hormone mix may cut breast cancer risk in menopausal women - Oct 20, 2009
- Hormone replacement therapy tied to breast cancer - Dec 30, 2011
- Estrogen therapy 'ups kidney stones risk' in postmenopausal women - Oct 12, 2010
- Postmenopausal hormone therapy 'ups breast cancer risk' - Oct 20, 2010
- Smoking linked to increased risk of breast cancer - Jan 25, 2011
Tags: acceptable length, affairs medical center, cancer institute, cancer registry, estrogen plus progestin, hormone replacement therapy, hrt, lifestyle study, lung cancer, lung cancer risk, menopausal symptoms, observation period, ohsu, oregon health, postmenopausal, science university, smoking age, study criteria, veterans affairs medical, veterans affairs medical center